RESULTS	Rhinoconjunctivitis symptoms were significantly lower in patients treated with high dose of CYT003-QbG10 as compared with placebo ( scores 0.31 vs. 0.52 , P = 0.04 ) based on a standardized average combined symptom and medication score .\